Cleveland Clinic: Dual-acting drug that can help patients with osteoporosis prevent additional fracture is top medical innovation for 2020

The FDA's approval of a new dual-acting drug is giving patients with osteoporosis more control against future fractures. It was named the top innovation for 2020.
Published: 4:33 PM EDT October 23, 2019